Medical Director of Hematology-Oncology at Connecticut Children’s; Professor at The Jackson Laboratory
The Jackson Laboratory
Ching Lau serves as the Medical Director of Hematology-Oncology at Connecticut Children’s, as Professor at JAX where he specializes in pediatric brain and bone tumor research, and as Head of the Division of Pediatric Hematology-Oncology in the Department of Pediatrics at the UConn School of Medicine. His clinical interests include neuro-oncology, solid tumors, and osteosarcoma.
Development of Preclinical Models of Pediatric Ependymoma
Preclinical models are used to mimic conditions of the human body and allow researchers to perform drug screening before use on a patient. There is a lack of robust preclinical models for ependymoma, and using samples provided by CBTN researchers are seeking to close this gap.
Ching Ching Lau
Ependymomas arise from ependymal cells that line the ventricles and passageways in the brain and the center of the spinal cord. Ependymal cells produce cerebrospinal fluid (CSF). These tumors are classified as supratentorial or infratentorial. In children, most ependymomas are infratentorial tumors